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Prolonged exposure to abnormally high calcium concentrations is thought to be
a core mechanism underlying hippocampal damage in epileptic patients; however,
no prior study has characterized calcium activity during seizures in the live, intact
hippocampus. We have directly investigated this possibility by combining whole-brain
electroencephalographic (EEG) measurements with microendoscopic calcium imaging
of pyramidal cells in the CA1 hippocampal region of freely behaving mice treated
with the pro-convulsant kainic acid (KA). We observed that KA administration led to
systematic patterns of epileptiform calcium activity: a series of large-scale, intensifying
flashes of increased calcium fluorescence concurrent with a cluster of low-amplitude
EEG waveforms. This was accompanied by a steady increase in cellular calcium levels
(>5 fold increase relative to the baseline), followed by an intense spreading calcium
wave characterized by a 218% increase in global mean intensity of calcium fluorescence
(n = 8, range [114–349%], p < 10−4; t-test). The wave had no consistent EEG
phenotype and occurred before the onset of motor convulsions. Similar changes in
calcium activity were also observed in animals treated with 2 different proconvulsant
agents, N-methyl-D-aspartate (NMDA) and pentylenetetrazol (PTZ), suggesting the
measured changes in calcium dynamics are a signature of seizure activity rather
than a KA-specific pathology. Additionally, despite reducing the behavioral severity of
KA-induced seizures, the anticonvulsant drug valproate (VA, 300mg/kg) did not modify
the observed abnormalities in calcium dynamics. These results confirm the presence of
pathological calcium activity preceding convulsive motor seizures and support calcium as
a candidate signaling molecule in a pathway connecting seizures to subsequent cellular
damage. Integrating in vivo calcium imaging with traditional assessment of seizures could
potentially increase translatability of pharmacological intervention, leading to novel drug
screening paradigms and therapeutics designed to target and abolish abnormal patterns
of both electrical and calcium excitation.
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INTRODUCTION
The lives of patients with seizures are impaired not only
during convulsive episodes, but also by compromised mood
and cognitive function (García-Morales et al., 2008; Mula and
Monaco, 2011; reviewed in Lin et al., 2012). One of the main
reasons for functional cognitive decline in seizure patients is
damage to the hippocampus following seizures; however, the
reason for seizure-induced hippocampal damage remains elusive
(reviewed by Thom, 2014). Dysregulation of cellular calcium
homeostasis has long been implicated as a key component of
seizure-related brain damage because of the well-established role
of calcium in excitotoxicity (Berdichevsky et al., 1983; Choi,
1988). Since seizure activity has been historically associated
with excessive neuronal excitability and synchronization (Jasper
and Penfield, 1954), excessive calcium influx through voltage-
dependent calcium channels (reviewed by Mehta et al., 2013)
during seizures may seem like the most likely cause. However,
it is now clear that if seizures are observed in live animals
(Matsumoto and Ajmone-Marsan, 1964) or human patients
(Truccolo et al., 2011), the observed synchronization does
not necessarily involve neuronal hyperactivity. Furthermore,
desynchronization is often observed during early stages of
seizures while synchronous states may actually contribute to
seizure termination (reviewed by Jiruska et al., 2013). Thus, the
relationship between seizure activity in the brain and potential
increases in intracellular calcium remains unclear. To establish
pathologically elevated calcium as a mechanistic link between
seizure activity and hippocampal damage, it is necessary to
directly observe calcium dynamics in the hippocampus of live
animals undergoing seizures; however, due to prior technical
limitations, these studies have not yet been performed.
In this study, we combined well established assessments
of seizure activity such as behavioral monitoring and whole-
brain EEG with functional large-scale real-time microendoscopic
imaging of the calcium indicator GCaMP6f in the CA1 region
of the hippocampus (Ghosh et al., 2011) in mice treated with
a single systemic dose of the pro-convulsant KA. KA induces
seizures by direct activation of kainate receptors, which leads to
increased excitability in limbic structures (reviewed by Vincent
and Mulle, 2009; Carta et al., 2014) and is a widely accepted
model of human temporal lobe epilepsy and treatment-resistant
epilepsy (Tse et al., 2014; reviewed by Lévesque et al., 2016).
Systemic KA injection has the advantage of better experimental
control of seizure timing and severity, as compared with genetic
animal models of epilepsy or electrical/chemical kindling models
that give rise to spontaneous recurrent seizures. Additionally,
systemic dosing avoids any unwanted physical effects stemming
from direct injection into the brain. To rule out the possibility
that the changes in calcium activity following KA administration
were associated with excitotoxic effects specific to KA, we imaged
animals dosed with two other mechanistically distinct pro-
convulsants: PTZ and NMDA.
The integrated approach of physiological calcium imaging
used in this study revealed distinct aberrations in hippocampal
calcium dynamics that occurred not only during seizures, but
also before behavioral or electroencephalographic signatures of
convulsive motor seizures became apparent. These included
altered intracellular calcium levels that were considerably higher
than normal, supporting the idea of excitotoxic levels of
cellular calcium as a mediator of neurodegeneration during
seizures. Surprisingly, the commonly prescribed anticonvulsant
valproate (VA) (Kanner and Balabanov, 2002) did not modify
the observed seizure-related abnormalities in calcium dynamics,
despite reducing the behavioral severity of KA-induced seizures.
MATERIALS AND METHODS
Drugs
The VA, PTZ, NMDA (Sigma-Aldrich, St. Louis MO, USA) and
KA (Tocris, Bristol, UK) were formulated before each imaging
session in 0.9% sodium chloride (Baxter, Deerfield IL, USA).
Seizure Assessment
Animals were continuously monitored and scored at 2min
epochs according to the most severe stage of a modified Racine
scale (Racine, 1972): 0: no changes in the behavior or EEG;
1: sudden behavioral arrest and motionless staring, simple low
amplitude EEG spikes; 2: intermittent ear twitches or hiccups,
spikes and sharp EEG waves with the amplitudes lower than a
typical amplitude observed during the slow-wave sleep; 3: clonus
of the head or forelimbs, tail rigidity, intermediate EEG spikes
or poly-spikes with the amplitudes exceeding typical amplitude
during the slow-wave sleep; 4: generalized clonic seizures with
rearing; complex high frequency and amplitude EEG spike-
waves; 5: generalized tonic-clonic seizures with loss of posture,
falling and/or wild jumping. A seizure stage 3 or higher was
classified as a convulsive motor seizure (CMS; Tse et al., 2014;
Puttachary et al., 2015). Seizure latency was defined as the time
period (in minutes) required to reach CMS. The dose of KA used
in this study (15mg/kg, subcutaneous) evoked seizure symptoms
in all animals. Most reached CMS, but none developed stage 5
seizures.
Animals
All procedures were performed in accordance with the
Guide for the Care and Use of Laboratory Animals (US
National Institutes of Health). Male C56BL/6J mice (n = 22)
aged 8–12 weeks underwent two separate surgeries under
Isoflurane (1.5–2.5%) with analgesic treatment (Buprenex,
0.05mg/kg subcutaneous): (1) to inject viral vector
(pENN.AAV.CamKII.GCaMP6f.WPRE.SV40, titer 7.3e12
GC/ml, 400–650 nL, diluted in PBS 1:10–1:15) and (2) to implant
an optical guide tube over CA1. During the second surgical
procedure, a subset of animals also received a subcutaneously
implanted telemetric device (PhysioTel F20-EET; Data Sciences
International, St. Paul, MN) for polysomnographic recordings
(Shelton et al., 2009; Berdyyeva et al., 2014). In the animals
equipped for telemetry, we coupled the devices to two sets of
stainless steel electrodes: one implanted in the frontal cortex and
superior/inferior colliculus for the whole-brain EEG (Figure 1);
the second in dorsal nuchal muscles for the electromyogram
(EMG; data not shown). The placement of the electrodes for the
whole-brain EEG recordings was dictated by our goals to (a)
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FIGURE 1 | Position of the implanted EEG electrodes and the
microendoscopic calcium imaging device for the combined telemetric
and calcium imaging recordings. (A) Schematic representation of the
imaging device and the EEG electrodes. (B) Optical guide tube (green circle)
stereotaxically centered over AP = −2.3mm, ML = 1.89mm, V = −1.6mm
from Bregma. The EEG elecrodes (blue circles) for the whole-brain EEG were
implanted in the frontal cortex and superior/inferior colliculus, respectively.
avoid any damage to the hippocampus that would compromise
the imaging procedure; and (b) simultaneously examine the
whole-brain EEG activity to bring our experimental design
closer to the readout in seizure patients. A group of animals
with telemetric devices only (n = 6) was used as a control to
verify that manipulations related to the imaging procedures did
not change the seizures’ parameters. The mice were allowed to
recover for 4–6 weeks. Histological examination was performed
after imaging experiments. Some animals (n = 7) were excluded
from the analysis due to the suboptimal quality of the tissue,
imaging artifacts, or low cellular yield.
Telemetric Recordings and Analysis
EEG, EMG and locomotive signals were continuously recorded
(100Hz sampling rate, Dataquest A.R.T. software) during the
imaging session and scored using Neuroscore software (Data
Science International). The EEG recordings were binned into
10-s intervals and classified into epileptiform spike types 0–5 as
described in the literature (Tse et al., 2014) and in the “Seizure
assessment” section above. The alignment between the imaging
system, EEG, and locomotive signals was done by recording, on a
separate channel of the polysomnographic system, the state of the
imaging system transmitted through an analog channel in nVista
and subsequently digitized at 100Hz (Berdyyeva et al., 2014).
Only the animals with <50ms discrepancy (n = 5) were used
to quantify the correlation between the EEG and imaging data.
Calcium Imaging Procedure
All imaging sessions were conducted in mice freely behaving in
their home cage. At the session onset, an integrated miniature
microscope (nVista, Inscopix, Palo Alto) was attached to a
skull-mounted baseplate under brief anesthesia (<1min, 0.5–1%
Isoflurane). Approximately 60min later the animals were dosed
with vehicle. To avoid potential photobleaching, continuous
imaging periods lasted less than 10min, with at least 5min until
the next imaging interval. After collecting 20–30min of post-
vehicle data, the animals were treated with either KA, NMDA
(75mg/kg, intraperitoneal) or PTZ (45mg/kg subcutaneous) and
imaged as above. One group of animals was pre-treated with VA
(300mg/kg intraperitoneal) 15min before the KA injection. The
imaging session was terminated once a seizure exceeding stage 3
was observed (with one exception to observe additional events)
or at a maximum duration of 90min post-KA. At the end of the
session, the animals were humanely euthanized.
Analysis of Imaging Data
The mean intensity of each video frame was extracted and
analyzed using custom written ImageJ and Matlab scripts. The
data were z-transformed to determine the wave peak and
half-max width (WHMW).
The analysis of cellular effects was performed using PCA-
ICA matrix decomposition (Mukamel et al., 2009; Frady and
Kristan, 2015) on the following data fragments: post-vehicle
(ten 1-min fragments), post-KA but before the first identifiable
wave (five 1-min fragments), and during the rapid-flashing and
fluorescence build-up (∼30 s). PCA-ICA uses correlations in the
pixels to factorize the imaging data, which allows the neurons
to be separated from the background; further smoothing of
neural responses was used to minimize impact of background
on measured calcium responses. Non-neuronal components
of PCA-ICA decomposition were manually removed. Calcium
events were identified by searching each neuronal calcium trace
for local maxima with peak amplitude >1 standard deviation
(s.d.) from the median of the trace with a decay time >200ms.
The one-tailed Wilcoxon Signed Rank (WSR) test was used to
compare event rates across the conditions.
To understand the calcium build-up during the epileptiform
activity, we compared the calcium activity of each neuron during
the build-up to its typical calcium transients in the post-vehicle
time periods. Since the absolute fluorescence intensities can
vary across cells based on levels of calcium indicator expression
and light intensity, we computed two normalized metrics to
characterize the build-up events for each cell. The Log Peak Ratio
was calculated by first finding the peak value of the calcium
build-up event for a given cell and then dividing that value by
the average of the 5 largest calcium transient peaks observed
for that same cell during the post-vehicle period prior to KA
administration.
Log Peak Ratio (n) = Log
(
Peak Buildup (n)
mean
(
Peak Top 5 spikes (n)
)
)
The resultant normalized values were then plotted and reported
for all cells on a base-10 log scale. The Log Integral Ratio was
calculated by first finding the integral of the calcium build-up
event for a given cell and then dividing that value by the average
of the 5 largest calcium transient integrals observed for that same
cell during the post-vehicle prior to KA administration.
Log Integral Ratio (n)=Log
(
Integral Buildup (n)
mean
(
Integral Top 5 spikes (n)
)
)
Again, the resultant normalized values were then plotted and
reported for all cells on a base-10 log scale.
Frontiers in Neuroscience | www.frontiersin.org 3 February 2016 | Volume 10 | Article 53
Berdyyeva et al. Epileptiform Calcium Motifs in Mice
RESULTS
KA Administration Led to Stereotypical
Patterns of Epileptiform Calcium Activity
The typical progression of events following KA administration
is illustrated in Figure 2A. All animals treated with KA (n = 8)
exhibited a series of flashes in GCaMP6f fluorescence across
the entire imaging field that escalated in both frequency
and intensity and were accompanied by a steady increase in
fluorescence within the cell bodies (Video 1). This pattern
(Figure 2B, black trace) was concurrent with a brief cluster
of low-amplitude EEG spikes (Figure 2B, green trace) and
was consistently and immediately followed by one or two
waves of high-intensity fluorescence spreading across the
field with a speed of approximately 1 cm/min (Video 1);
the fluorescence behind the wavefront dissipated over
1–3min.
The waves were characterized by a continuous increase in
global mean fluorescence intensity followed by a continuous
decrease (Figure 2C, bottom, black trace). During the first
identifiable wave, the average fluorescence increase was 218%
relative to baseline (n = 8, range [114–349%]) and was highly
significant (p < 10−4; t-test). The average duration of the wave,
as assessed as the wave half-maxwidth (WHMW), was 31 s (range
[16–69 s], n = 8).
On average, the first identifiable wave was observed 19.9min
after KA administration, (range [4.2–44]) and was not associated
with any convulsive behaviors. The typical behavioral and
EEG (Figure 2C, bottom, green trace) phenotypes were ones
associated with stage 1–2 seizures (see Methods, “Seizure
Assessment”). In the majority of the animals (6 out of 8), the
sequence of rapid flashing, fluorescence build-up and a wave
reappeared later in the session but before the onset of motor
convulsions (that, if observed during a given session, occurred
on average 33min after the initial wave; range [23–49]).
Half of the animals (n = 4) exhibited a third type
of epileptiform signature: steady, low frequency (0.2–0.8Hz)
fluorescent flashes (Figure 1D, bottom, black trace) that, in most
animals (3 out of 4), also occurred before the onset of the CMS.
These varied in intensity but were highly synchronized with
epileptiform EEG spikes (Figure 2D, bottom): if a fluorescence
spike was detected in a given 100ms bin (2 imaging frames), the
EEG spike was detected within the same bin with significantly
greater than chance probability (90.2% on average, [82.5–95%]
range, p < 0.001, χ2 test). In the data combined across animals
(n = 3), the correlation between detected spike peaks in imaging
and EEG was highly significant (R2 = 0.9994, p < 0.0001).
To confirm that the observed abnormalities in calcium
activity following KA administration were associated with seizure
induction rather than effects specific to KA, we imaged animals
FIGURE 2 | Overview of Epileptiform Calcium Motifs following KA Administration (15mg/kg s.c.) in Hippocampal CA1 of a Freely Behaving Mouse. (A)
Simultaneous EEG (green) and calcium (black) activity following KA administration (arrow). The animal in this example never reached a convulsive motor seizure (CMS).
Background shading indicates EEG seizure scores. The three stereotypical events are indicated: rapid-flashing and build-up (B), calcium waves (C), and slow-flashing
(D). (B–D) Expanded views illustrating patterns of rapid flashing and cellular calcium build-up (B), calcium wave (C), and slow flashing (D). The imaging frames (top)
show the levels of fluorescence at different time points (Scale: 20µm, horizontal bar; and 0–200% change in fluorescence, vertical gray scale bar). The mean frame
intensity (black) and EEG (green) traces are plotted at the bottom with the imaging frame positions indicated by the numbers 1–6.
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dosed with two other mechanistically distinct pro-convulsants:
PTZ (n = 2) and NMDA (n = 2). We observed similar
epileptiform fluorescence changes in the majority of animals
(50% of animals dosed with PTZ and 100% dosed with NMDA
had at least one identifiable wave before the CMS onset;
Supplementary Figure 1). The peak fluorescence increases were
comparable across groups (KA: average 218%, PTZ animal: 173%,
NMDA animals: 209 and 222% increase), however the waves in
PTZ and NMDA groups had a faster onset, slower decline and
more narrow WHMW (KA: average 31 s, PTZ: 19.9 sec; NMDA:
17.1 and 18.7 s). Interestingly, the wave in PTZ but not NMDA
animals was preceded by a series of brief intensifying flashes
typically observed with KA.
Effects of KA Administration on Individual
Cells: Decreased Rate of Calcium
Transients and Increased Calcium Build-Up
To assess effects of KA on cellular calcium activity, we
analyzed three periods preceding the calcium wave: post-
vehicle spontaneous activity, early post-KA activity, and periods
with rapid flashing and build-up. Representative examples of
cellular fluorescence intensity changes for these three periods
are plotted in Figures 3A–C. Figure 3A illustrates typical post-
vehicle calcium transients, Figure 3B shows early post-KA
activity; and Figure 3C shows the build-up during the rapid
flashing (the same scale was used in Figures 3A–C highlighting
the increased intracellular calcium).
To quantitatively examine the cellular effects of KA (100–
150 neurons per animal, n = 4 animals), we computed
differences in the rates of spontaneous calcium transients
between post-vehicle and the early post-KA periods. All animals
had a significant decrease in event frequency following KA
administration (average reduction of 1.5 events/min; p < 10−9
in each animal, WSR test).
In order to quantify each of the “calcium build-up” events
detected in the cellular traces, we computed two metrics and
normalized them to the average spontaneous calcium transients
observed post-vehicle and prior to KA administration (see
Materials and Methods). The Log Peak Ratio is a measure
of the maximum fluorescence intensity observed for each cell
during the “calcium build-up” event and the Log Integral Ratio
is a measure of the fluorescence intensity integrated over the
full duration of the “calcium build-up” event (Figure 3D). The
rightward shift of the peak and integral ratio distributions (base-
10 log scale) computed for each animal and combined across
animals (n = 4, Figure 3E) indicates higher than normal levels of
calcium load in the time periods anticipating convulsive activity
(on average, 0.67 ± 0.235 log peak ratio, 5-fold increase in the
median peak; and 1.17 ± 0.35 log integral ratio, 20-fold increase
in median integral, p < 10−5 and p < 10−10 respectively, t-test).
VA Did Not Prevent Epileptiform Changes
in Calcium Activity Following KA
Administration Despite Reducing
Behavioral Severity of KA-Induced
Seizures
We investigated whether pre-treatment (15min) with VA had
any impact on post-KA changes in calcium dynamics. The group
of animals pre-treated with VA (VAKA, n = 11) had significantly
reduced severity of behavioral seizures relative to the KA group
(KA, n = 11) (p = 0.0019, one-tailed Mann–Whitney U-test)
and a lower proportion that reached CMS (27 vs. 91%, p =
0.0046, χ2 test with Yates’ correction; Supplementary Table 1).
A representative imaging session of a VAKA animal is shown
in Figure 4A. Pre-treating with VA did not abolish KA-induced
epileptiform calcium events (Figures 4B–D). The only noticeable
difference observed was a tendency toward bouts of rapid
flashes without subsequent calcium waves in the VAKA group
(Figure 4B). Similarities in the sequence of epileptiform calcium
motifs in representative examples from the KA andVAKA groups
are illustrated in Figure 4E.
All imaging videos collected in VAKA animals (n = 7)
had at least one identifiable calcium wave pattern. Since the
VAKA animals reached CMS significantly less often than KA
animals, and tended to have longer CMS latencies, the number
FIGURE 3 | Analysis of Cellular Events in Hippocampal CA1 of the Mice Treated with KA. (A) Five representative cellular calcium traces prior to KA
administration; detected calcium transient events indicated by “x” marks. (B) Same traces after KA administration but before calcium build-up. (C) Same traces during
the calcium build-up; same scale as in (A,B). (D) The peaks (red x) and integrals (cyan shading) of a representative cell: the 5 largest post-vehicle events (top)
compared to a typical build-up event (bottom, same scale as on top). The events’ beginning and end are marked with blue “x”s. (E) Distributions of the build-up event
peak amplitude (red histogram, top) and integral (cyan histogram, bottom) combined across animals (10 log x-axis scale).
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FIGURE 4 | Epileptiform motifs in CA1 of Mice Pre-Treated with VA (300mg/kg, i.p.) 15min Prior to KA Administration. (A–D) A representative session (A)
of an animal pre-treated with VA before KA administration (VAKA) exhibited isolated flashing (B), but otherwise had similar epileptifom patterns (C,D) as animals
treated with KA only. (E) Occurrences of stereotypical events (1, rapid-flashing and build-up; *, calcium wave; __, slow-flashing) are marked in four representative
VAKA (top) and KA (bottom) sessions. Background color indicates EEG seizure scores. Red “x” indicates the onset of CMS. (F) Mean normalized fluorescence
intensities during the first identifiable wave were aligned with respect to peak time and plotted across time (left: KA animals; right: VAKA animals). (G) Analysis of
individual neurons with respect to the characteristics of calcium-build-up events (the Log Peak Ratio and Log Integral Ratio) showed no significant differences in the
VAKA group compared with the KA group.
of waves occurring before CMS was higher than in the KA
group (14 waves were detected pre-CMS in 8 KA animals,
19 waves were detected in the 7VAKA animals). The similar
characteristics of the first identified wave in both groups are
illustrated in Figure 4F. Statistical comparison of mean wave
intensities showed no significant differences between the groups
(KA group: 218% increase; VAKA group: 239% increase, p =
0.14, t-test). Wave duration was similar as well: the WHMW in
the VAKA group (23.7 s) was not significantly different from the
KA group (31 s, p = 0.42; t-test).
We performed the same cellular level analysis in VAKA
animals as with the KA animals. In VAKA animals, we found
a similar reduction in the calcium transient rate in the early
post-KA period (average reduction of 1.1 events/min, p < 10−10
for each animal, WSR); as well as similar responses during the
rapid-flashing and calcium build-up motif (Figure 4F, VAKA
group: 0.77 ± 0.15 log peak ratio, p < 10−13, t-test; 1.37 ± 0.32
log integral ratio, p < 10−13, t-test, p < 10−9 WSR; no significant
differences between VAKA and KA group: 0.67 and 1.17 for the
log and integral respectively).
DISCUSSION
The decline in mood and cognition in epileptic patients is
thought to be a consequence of seizure-induced damage to
relevant brain structures such as the hippocampus (Olney
et al., 1986; Kienzler et al., 2009; Jafarian et al., 2015). In
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turn, an established connection between pathologically elevated
calcium influx and cellular damage links seizures to neuronal
degeneration (Heinemann, 1986; Meldrum, 1986; Staley, 2015;
reviewed in Delorenzo et al., 2005; Henshall andMeldrum, 2012).
While it is widely hypothesized that abnormal levels of calcium
could be a key component of seizure-related excitotoxicity
leading to the hippocampal damage (Sztriha et al., 1985;
Meldrum, 1986; Nagarkatti et al., 2009; Cao et al., 2015), due to
technical limitations, no previous study has addressed whether
aberrant calcium dynamics are actually observed in hippocampal
neurons of mammals undergoing seizures.
Here, we combined well established assessments of
pharmacologically induced seizure activity (i.e., behavioral
monitoring and the whole-brain electroencephalography)
with large-scale real-time cellular calcium imaging. The use
of miniature fluorescence microscopes in freely moving mice
suggests that the long-hypothesized pathological patterns of
calcium during a seizure in the hippocampus of awake behaving
animals not only occurs, but also occurs to a great extent (during
the calcium wave, the average fluorescence increase was 218%
relative to baseline). In following studies, it would be important
to determine if the intense calcium waves that we observed could
directly lead to an acute cellular damage in live animals.
An unexpected finding of this study was that the significant
deviations from normal calcium dynamics in CA1 arose before
(33min, on average) the onset of motor convulsions. Previous
studies utilizing in-vivo time-lapse imaging methods (Daniel
et al., 2015) compared neuronal morphology before and after
seizure induction and found that the most severe seizures
acutely damaged dendritic structures (Mizrahi et al., 2004;
Rensing et al., 2005), possibly through calcium-dependent actin
depolymerization (Zeng et al., 2007). A more recent study found
that even brief convulsive seizures (<5min) induced dendritic
beading and spine loss (Guo et al., 2012) supposedly via the
samemechanism, although intracellular calciumwas not studied.
Our finding that individual hippocampal neurons exhibited a
significantly higher than normal calcium load before the onset of
motor convulsions indicates that paroxysmal motor convulsions,
despite being the most readily noticeable symptom of seizures,
could be a mere expression of latent pathological changes within
the CNS of seizure patients (reviewed in de Lanerolle et al.,
2012; Staley, 2015). Furthermore, the intense calcium waves
were observed in the absence of any consistent whole-brain
EEG phenotype typically associated with seizure activity. It is
also possible that the EEG signals we observed may instead be
a result of seizure propagation rather than seizure initiation.
Indeed, electrographic definition of the seizure activity could
be dependent on the proximity of the electrode placement to
the seizure focus. To take into account the whole-brain EEG
recordings of our study, we defined the seizure latency as
a time required to reach CMS (Tse et al., 2014; Puttachary
et al., 2015) that is characterized by clonus of the head or
forelimbs, tail rigidity, intermediate EEG spikes or poly-spikes
with the amplitudes exceeding typical amplitude during the
slow-wave sleep. While we examined the EEG activity on the
surface of the cortex to parallel the readout in patients, it is
possible that the EEG signatures of seizures would be observed
simultaneously with the calcium wave if the electrodes and the
calcium imaging device were placed directly in the seizure focus
within the hippocampus. These additional studies would be an
important subject for future applications of the novel integrated
methodology introduced here.
There are two major reasons as to why current seizure
medications may be inadequate: (1) incomplete understanding of
the underlying pathophysiological mechanisms; (2) inadequate
screening methods that favor agents which ameliorate symptoms
but not the underlying pathologies. The latter point is illustrated
by our finding that VA, a commonly prescribed anticonvulsant
(Kanner and Balabanov, 2002), did not normalize abnormal
calcium dynamics following administration of KA, despite having
protective effect against CMS. We selected VA for this study
as it is one of the oldest and most commonly prescribed
anticonvulsants in humans (Meunier et al., 1963; Pinder et al.,
1977; Tunnicliff, 1999; Who Model List of Essential Medicines,
2013; reviewed by Perucca, 2002). We applied VA at a dose
(300mg/kg) that doesn’t change behavior or EEG activity
(Roucard et al., 2010) but has protective effect in mice (Brahmane
et al., 2010; Löscher et al, 2013); injected systemically with a
single dose of KA (Abdel-Rahmanm et al., 1999). We selected
the KA seizure induction model as it is one of the most
widely used model of seizures that mimics the features and
pathophysiology of temporal lobe epilepsy in humans (reviewed
by Ben-Ari, 1985; Fisher, 1989; Vincent and Mulle, 2009;
Lévesque et al., 2016). In confirmation of the previous studies,
we found that VA treatment reduced the severity and delayed
the onset of the seizures. However, VA did not alleviate calcium
abnormalities observed after KA treatment. While testing the
effects of other known anticonvulsants on the epileptifotm
calciummotifs remains an important objective of the subsequent
studies, the current result demonstrates that VA, a commonly
used anticonvulsant, can alleviate motor symptoms but not
necessarily the associated pathological processes. This finding can
potentially provide an insight as to why current treatments for
epilepsy are inadequate (García-Morales et al., 2008; Mula and
Monaco, 2011). Therefore, large-scale in-vivo calcium imaging
could be a valuable screening platform for novel antiepileptic
drugs that can abolish the abnormal patterns of both electrical
and calcium excitation.
One potential limitation of this study is that is that we only
examined one method of seizure induction - acute systemic
administration of a chemical proconvulsant agent. While we
ruled out a KA-specific pathology by finding similar changes in
calcium activity in animals treated with 2 other mechanistically
distinct proconvulsants, NMDA and PTZ, the abnormal patterns
in calcium activity as described here may not represent de novo
epileptiform origins or propagations. NMDA directly activates
NMDA receptors leading to the initiation and spreading of a
depolarization that is often used to evoke and study infantile
spasms (reviewed by Stafstrom andHolmes, 2002; Galanopoulou,
2013), status epilepticus (SE, reviewed by Wasterlain et al.,
2013), and seizure-related excitotoxic damage (Cruz et al., 2003;
Milhaud et al., 2003; Chang-Mu et al., 2010). In contrast
to KA and NMDA, PTZ antagonizes GABAergic inhibition
and is often used to model acute generalized convulsions
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(reviewed by Löscher, 2009). It is also possible that the
different modes of seizure induction such as electrical kindling
or spontaneous seizures in the genetic animal models that
cause lesser damage in the hippocampus evoke different or no
epileptiform calcium motifs. These additional studies will be
the subject of future applications of the technique. Interestingly,
however, a recent study by Cao et al. (2015) demonstrated
similar KA-induced patterns of calcium activity in cultured
hippocampal neurons. The second limitation of this study is
that the changes in intracellular calcium were inferred from
changes in fluorescence of the GCaMP6f calcium sensor. The
effects observed here deviated from normal activity patterns
to such an extent that they could saturate the sensor and
therefore compromise its ability to accurately report changes in
calcium levels. In addition, the non-continuous imaging regime
used to minimize potential phototoxicity and the conservative
statistical analysis could potentially result in an underestimation
of the magnitude of seizure-related abnormalities in calcium
dynamics.
Calcium imaging in freely behaving animals at single cell
resolution opens a new possibility for investigating molecular
mechanisms of seizure pathophysiology previously inaccessible
by traditional methods. Our findings support calcium as a
candidate signaling molecule on a pathway connecting seizures
to subsequent cellular damage. Given that calcium is one
of the most important neuronal second messenger systems
(Berridge, 1998), controlling a variety of functions including
cell integrity (Zeng et al., 2007), energy metabolism (Zsurka
and Kunz, 2015) and cell death (Paschen, 2003), the novel
screening paradigm introduced here may lead to a better
understanding of the mechanisms behind various CNS diseases
and potentially increase translatability of novel pharmacological
intervention, leading to novel drug screening paradigms and
therapeutics.
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Video 1 | Overview of Stereotypical Epileptiform Motifs. Videos of the
epileptiform motifs are presented in real-time. Changes in calcium sensor
fluorescence are presented on a log-contrast scale in order to visualize the
changes within individual cells during the flashing and wave epileptiform patterns,
which differed in intensity by orders of magnitude. Concurrent EEG activity is
plotted below the imaging video. M190 KA: Rapid Flashing & Build Up: After a
period of quiescence, flashes of calcium activity (concurrent with low-amplitude
epileptiform EEG waveforms) are visible. As the flashes continue, individual cell
bodies gradually increase in fluorescence with a varied timecourse. Calcium Wave:
Immediately following the build-up, one or two concurrent waves propagate
across the field of view. EEG activity shows no identifiable phenotype. After the
wave, the increased fluorescence slowly decays. Slow Flashing: After one or more
sequences of rapid flashing and waves, the calcium and EEG activity in some
animals enters a prolonged period of slow calcium flashing/EEG spiking. The
calcium within cell bodies either remains elevated or follows the flashing pattern.
M182VA+KA: In animals pre-treated with VA, isolated rapid-flashing and build-up
with no subsequent calcium wave was observed; otherwise the calcium
epileptiform events were similar to the KA group.
Supplementary Figure 1 | Mean normalized fluorescence intensities
during the first identifiable wave were aligned with respect to peak time
and plotted across time (red and blue, NMDA treatment; green, PTZ
treatment). Same scale as Figure 4F.
Supplementary Table 1 | Assessment of seizure severity in different
groups of mice. A seizure stage 3 or higher (“Materials and methods, Seizure
assessment”) was classified as a convulsive motor seizure (CMS). Seizure latency
was defined as the time period (in minutes) required to reach CMS. No significant
differences were found between mice implanted with telemetric device only
(“TEL”), and mice implanted with both telemetric and imaging device (“TEL+IMG”).
Pre-treatment with VA significantly reduced behavioral severity of seizures
(p = 0.0019, one-tailed Mann–Whitney U-test), and significantly lowered the
proportion of animals that reached CMS (10 out of 11 animals in “KA” group vs. 3
out of 11 in “VA+KA” group; p = 0.0046, one-tailed chi-square test with Yates’
correction).
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